Ambu
Ambu A/S, commonly referred to as Ambu, is a leading global provider of innovative medical devices headquartered in Denmark (DK). Founded in 1937, the company has established a strong presence in the healthcare industry, particularly in the fields of anaesthesia, patient monitoring, and emergency care. Ambu is renowned for its unique single-use endoscopy solutions and advanced airway management products, which enhance patient safety and streamline clinical workflows. With a commitment to quality and innovation, Ambu has achieved significant milestones, including the launch of its groundbreaking Ambu® aScope™. Today, Ambu operates in key markets across Europe, North America, and Asia, solidifying its position as a trusted partner in the medical community. The company’s dedication to improving patient outcomes and its robust product portfolio have earned it a notable reputation in the healthcare sector.
DitchCarbon Score
How does Ambu's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ambu's score of 76 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ambu's reported carbon emissions
In 2024, Ambu A/S reported total greenhouse gas emissions of approximately 209,157,000 kg CO2e, with emissions distributed across various scopes: 3,369,000 kg CO2e from Scope 1, 15,400,000 kg CO2e from Scope 2 (market-based), and a significant 190,388,000 kg CO2e from Scope 3. The total emissions for 2023 were about 160,923,000 kg CO2e, indicating a year-on-year increase. Ambu has set ambitious climate commitments, aiming to achieve net-zero emissions by 2045. This long-term target encompasses all scopes of emissions. In the near term, the company has committed to reducing absolute Scope 1 and Scope 2 GHG emissions by 75% by FY2030, using FY2021 as the baseline year. Additionally, Ambu aims for 82% of its suppliers, covering purchased goods and services, to have science-based targets by FY2027. The company’s emissions data and reduction targets are sourced directly from Ambu A/S, with no data cascaded from a parent or related organization. Ambu is a member of the Science Based Targets initiative (SBTi), ensuring that its targets align with the necessary reductions to limit global warming to 1.5°C.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,337,000 | 000,000 | 000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,886,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ambu is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
